Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for bioMerieux (BMXMF : OTC)
 
 • Company Description   
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France.

Number of Employees: 12,624

 
 • Price / Volume Information   
Yesterday's Closing Price: $91.68 Daily Weekly Monthly
20 Day Moving Average: 96 shares
Shares Outstanding: 118.36 (millions)
Market Capitalization: $10,850.77 (millions)
Beta: 0.60
52 Week High: $148.50
52 Week Low: $87.13
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -9.24% 3.15%
12 Week -17.41% -11.06%
Year To Date -34.52% -20.46%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
376 Chemin De l`Orme
-
Marcy l`Etoile,I0 69280
FRA
ph: 33-04-78-87-20-00
fax: 33-04-78-87-20-90
investor.relations@biomerieux.com http://www.biomerieux.com
 
 • General Corporate Information   
Officers
Alexandre Merieux - Chief Executive Officer and Chairman
Pierre Boulud - Chief Operating Officer
Philippe Archinard - Director
Jean-Luc Belingard - Director
Frederic Beseme - Director

Peer Information
bioMerieux (CHCR)
bioMerieux (ESRX)
bioMerieux (MYDP)
bioMerieux (GBCS)
bioMerieux (LAXAF)
bioMerieux (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: F1149Y232
SIC: 8880
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: 06/01/22
Share - Related Items
Shares Outstanding: 118.36
Most Recent Split Date: 9.00 (3.00:1)
Beta: 0.60
Market Capitalization: $10,850.77 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $4.32 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 06/01/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 21.22
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.89
Price/Cash Flow: 11.02
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - 2.31
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - 1.65
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - 22.94
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 31.73
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - 2.25
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.11
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - 10.26
09/30/21 - -
 

Powered by Zacks Investment Research ©